Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/dZiSCfbwoceSvmdVImgI

November 9, 2012
Sign upForwardArchiveAdvertiseRead more at SmartBrief.com
News for nuclear medicine and molecular imaging professionals
 
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at snmmi@smartbrief.com.

  Top Story 
  • SHINE says isotope facility should be ready in 2016
    SHINE Medical Technologies said it is on schedule to open its medical isotope facility in Janesville, Wis., in early 2016. The facility aims to fill the gap for molybdenum-99 supply when a reactor in Canada that produces the isotope closes in 2016. The company said it is preparing to start up a full-scale model accelerator for producing the isotope. It is also looking to send its final application to the Nuclear Regulatory Commission between March and June of next year. The Janesville Gazette (Wis.) (11/8) LinkedInFacebookTwitterEmail this Story
  Clinical News & Research 
  Industry Report 
  • Bayer, Medsintez to set up Russian facilities for drugs, imaging agents
    Bayer HealthCare and Russian firm Medsintez have entered into a deal to establish manufacturing facilities in Russia that will focus on diagnostic imaging agents and pharmaceutical products. The move is in compliance with the Russia 2020 plan, which strongly encourages companies wanting to sell products in the country to set up local manufacturing operations. In-PharmaTechnologist.com (11/8) LinkedInFacebookTwitterEmail this Story
  News from the Field 
  • Radiology administrators are not confident about reimbursements
    Radiology administrators are confident that their facilities will grow in the upcoming months and that operating and staff costs will be stable, according to data from the Medical Imaging Confidence Index, which covered the October to December period. Respondents, however, are not so optimistic regarding Medicare reimbursement for interventional and diagnostic imaging -- a consistent trend shown by the MICI. AuntMinnie.com (free registration) (11/8) LinkedInFacebookTwitterEmail this Story
  Health Policy 
  • Group recommends changes to proposed device ID rule
    The proposal to create a unique device identifier system for medical technologies is the "most extensive and complex FDA regulation to be issued in recent memory," and the agency should work to "get it right the first time," said Janet Trunzo of the Advanced Medical Technology Association. The group recommends certain changes be made to the proposed rule, including extending to two years the time required for makers of Class III medical devices to adopt UDI. MedCityNews.com (11/8) LinkedInFacebookTwitterEmail this Story
  • Governors, legislatures to decide ACA's future
    Governors in Texas, Florida and elsewhere have refused to set up insurance exchanges under the Affordable Care Act, Missouri voters passed a ballot measure prohibiting the state from doing so without the Legislature's approval, and some states are considering running their exchanges in partnership with the federal government. Officials in other states, such as New Jersey and Virginia, have laid the groundwork for insurance exchanges but were waiting to announce plans until after the election. Leaders of 11 states and Washington, D.C., said they will expand their Medicaid programs, six said they won't, and some are negotiating with HHS on the scope of expansion. Yahoo/The Associated Press (11/9) , Kaiser Health News (11/7) , The Hill/Healthwatch blog (11/7) LinkedInFacebookTwitterEmail this Story
  Advancing Health Care 
  • Researchers suggest ways to boost comparative effectiveness trials
    Studies that compare treatments can lack impact because of obstacles posed by aggressive marketing and financial incentives for certain treatments, because researchers ignore issues important to clinicians and patients, because providers are resistant to change and because the studies' results are ambiguous, according to an analysis in Health Affairs based on interviews with researchers. The analysis recommends matching financial incentives with recommendations for changes in practice and taking doctors' and patients' perspectives into account when designing studies. The New York Times (tiered subscription model)/Well blog (11/8) LinkedInFacebookTwitterEmail this Story
  From SNMMI 
SNMMI  |  News  |  Meetings  |  Education  |  Publications  |  Membership

SNMMI on Facebook  |  SNMMI on LinkedIn  |  SNMMI on Twitter  |  SNMMI on YouTube

  SmartQuote 
A man who does not read good books has no advantage over the man who can’t read them."
--Mark Twain,
American writer


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
   
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Advertise
Account Director:   Meryl Harold   (202) 407-7828
 
Read more at SmartBrief.com
 
 
 Recent SNMMI SmartBrief Issues:   Lead Editor:   Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.®  Legal Information